A new antiviral drug, molnupiravir, prevented half of severe COVID-19 infections, a study found

A new antiviral drug, molnupiravir, prevented half of severe COVID-19 infections, a study found: An experimental drug prevented half of COVID-19 infections that would otherwise have sent people to the hospital, according to a study released Friday